Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.63
0.28 (6.44%)
At close: Aug 15, 2025, 2:43 PM
Monte Rosa Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 24.17M | 6.15M | -72.7M | -119.39M | -130.41M | -135.28M | -135.35M | -132.88M | -125.32M | -116.61M | -108.5M | -101.16M | -93.68M | -85.61M | -73.96M | -70.17M | -56.89M | -43.85M |
Depreciation & Amortization | 8.34M | 8.27M | 8.12M | 7.91M | 7.64M | 6.97M | 6.22M | 5.45M | 4.64M | 4.14M | 3.75M | 3.48M | 3.03M | 2.61M | 2.13M | 1.55M | 1.14M | 740K |
Stock-Based Compensation | 18.94M | 18.55M | 18.13M | 17.73M | 17.92M | 17.57M | 16.67M | 15.92M | 14.67M | 13.39M | 11.66M | 10.19M | 9.05M | 7.2M | 5.2M | 3.54M | 1.52M | 595K |
Other Working Capital | -7.96M | 24.7M | 103.4M | 59.42M | 53.44M | 54.18M | 66.33M | 16.32M | 12.62M | 7.45M | -1.39M | -1.45M | 2.56M | 4.61M | 6.99M | 6.18M | 2.66M | -1.97M |
Other Non-Cash Items | -21.86M | -22.22M | -21.2M | -19.25M | -399K | -743K | -1.81M | -2.72M | -1.02M | 1.42M | 2.76M | 2.41M | 1.22M | 2.47M | 3.22M | 10.89M | 10.88M | 10.63M |
Deferred Income Tax | n/a | n/a | n/a | -2M | -2M | -2M | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K |
Change in Working Capital | -1.87M | 23.91M | 109.65M | 57.7M | 46.25M | 54.93M | 72.47M | 16.84M | 13.73M | 9.19M | -2.13M | 2.39M | 501K | 2.63M | 6.29M | 2.67M | 2.74M | 386K |
Operating Cash Flow | 27.72M | 34.67M | 42M | -57.29M | -61M | -58.56M | -43.8M | -97.4M | -93.29M | -88.47M | -92.47M | -82.68M | -79.87M | -72.95M | -59.36M | -53.77M | -42.86M | -33.49M |
Capital Expenditures | -3.86M | -4.19M | -3.99M | -5.49M | -6.75M | -11.24M | -19.04M | -24.62M | -24.36M | -20.41M | -12.91M | -8.7M | -9.05M | -9.2M | -9.73M | -7.86M | -7.03M | -5.59M |
Cash Acquisitions | n/a | n/a | n/a | -15.99K | -53.27K | 8.73K | 139.73K | 202.38K | 223.67K | 173.36K | 167.36K | 132.7K | 215.7K | 204K | 79K | 67K | n/a | n/a |
Purchase of Investments | -257.38M | -312.31M | -230.36M | -189.91M | -165.35M | -91.46M | -103.21M | -170.07M | -221.65M | -273.28M | -384.42M | -290.05M | -230.65M | -178.96M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 193.19M | 161.96M | 189.9M | 196.15M | 170.73M | 180.91M | 210.93M | 215.13M | 260.33M | 275.33M | 178M | 130.3M | 40M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 15.99K | 53.27K | 115.27K | -15.73K | -78.38K | -84.78K | -158.47K | 97.53K | 156.19K | 192.3K | 204K | 79K | 67K | n/a | n/a |
Investing Cash Flow | -68.05M | -154.53M | -44.45M | 741K | -1.38M | 78.33M | 88.8M | 20.57M | 14.43M | -18.37M | -219.22M | -168.33M | -199.5M | -187.96M | -9.65M | -7.79M | -7.03M | -5.59M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 231K | 231K | 231K | n/a | -231K | -231K | -409K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 48.27M | 48.27M | 48.27M | 656K | n/a | 1.2M | 1.22M | 1.6M | 1.38M | 276K | 411K | -103K | -1.44M | 203.94M | 203.55M | 203.68M | 204.98M | -671K |
Financial Cash Flow | 1M | 98.66M | 98.89M | 123.46M | 124.54M | 27.72M | 27.49M | 22.75M | 21.43M | 20.33M | 20.47M | -103K | 29.57M | 234.95M | 377.56M | 377.69M | 395.98M | 202.83M |
Net Cash Flow | -39.35M | -21.23M | 96.15M | 66.56M | 61.81M | 47.15M | 72.43M | -54.08M | -57.43M | -86.51M | -291.22M | -251.11M | -249.81M | -25.96M | 308.55M | 316.13M | 346.08M | 163.74M |
Free Cash Flow | 23.85M | 30.48M | 38.01M | -62.79M | -67.76M | -69.81M | -62.84M | -122.02M | -117.66M | -108.87M | -105.38M | -91.38M | -88.92M | -82.15M | -69.09M | -61.62M | -49.9M | -39.09M |